Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2
To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation...
Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting
The study was a retrospective cohort study of 313 consecutive hospitalized adult patients with coronavirus disease 2019 (COVID-19) pneumonia. The over...
Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2
To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation...
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
Convalescent plasma (CP) was previously used successfully to treat SARS-CoV-1 and MERS infections. Nine out of 10 patients who have received CP outsid...
Improving Detection Efficiency of SARS-CoV-2 Nucleic Acid Testing
SARS-CoV-2 nucleic acid testing (NAT) has been routinely used for diagnosis during this pandemic. There have been concerns about its high false-negati...
Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2
SARS-CoV-2 has caused a worldwide pandemic of coronavirus disease 2019 or COVID-19. Coronaviruses generate subgenomic RNAs through a process involving...
Autoimmune and Rheumatic Manifestations Associated With COVID-19 in Adults: An Updated Systematic Review
Numerous cases of the coronavirus disease 2019 (COVID-19) with autoimmune and rheumatic manifestations have been reported. Most of the existing eviden...
Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2
To prevent the novel coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2, it is necessary to perform early identification and isolation...